ELISA Analyzer Market Size
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 1.06 Billion |
| Market Size (2030) | USD 1.25 Billion |
| CAGR (2025 - 2030) | 3.50% |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
ELISA Analyzer Market Analysis
The ELISA Analyzer Market size is estimated at USD 1.06 billion in 2025, and is expected to reach USD 1.25 billion by 2030, at a CAGR of 3.5% during the forecast period (2025-2030).
The major factors that are expected to drive market growth are the widespread prevalence of infectious diseases and cancer and the rising demand for technologically advanced systems. Also, the rise in demand for automated and portable ELISA systems is projected to drive industry expansion over the coming years.
The surge in the prevalence of infectious diseases is expected to bolster the demand for ELISA analyzers, as ELIZA analyzers have a crucial role in detecting infectious diseases. For instance, according to the data published by the Joint United Nations Program on HIV and AIDS (UNAIDS), in August 2023, approximately 39.0 million people globally were living with HIV in 2022 compared to 38.7 million in 2021.
As per the same source, around 1.3 million people were newly diagnosed with HIV globally in 2022. Similarly, as per data published by the World Health Organization (WHO) in July 2022, approximately 67,000 new cases of hepatitis C and 10,000 cases of hepatitis B are reported in the United States every year. Thus, the surge in infectious disease led to a surge in ELISA testing, which, in turn, led to a rise in demand for ELISA analyzers, thereby driving the growth of the market.
Also, ELISA is employed to quantify antibody titers used to evaluate immunogenicity during vaccine development. For instance, according to the January 2024 update from Gyros Protein Technologies AB, immunoassays, including ELIZA analyzers, have a significant role in characterizing vector titer, vaccine titer, affinity, and purity of vaccine. Hence, the rise in vaccine development activities around the globe leads to a surge in demand for ELISA analyzers, thereby driving the growth of the market.
For instance, according to the November 2023 data of the Vaccines Europe, there were 103 vaccine candidates in the Vaccines Europe members’ pipeline. Among them, most vaccines are being developed to manage infectious diseases. Thus, the robust pipeline of vaccine candidates is projected to bolster the demand for ELIZA analyzers during the forecast period.
In addition, pharmaceutical companies such as GSK PLC and Sanofi have many vaccine candidates in the pipeline. For instance, Sanofi has 10 vaccine candidates in its pipeline, according to the latest updates at the Q2 2022 results meeting held in July 2022. Hence, the surge in vaccine development activities leads to a rise in demand for ELISA analyzers, thereby driving the growth of the market. However, the lack of skilled professionals and the low detection limit of existing technology is expected to hinder the market growth during the forecast period.
ELISA Analyzer Market Trends
Automated ELISA Analyzers are Expected to Witness High Growth During the Forecast Period
The increasing burden of infectious diseases globally has fueled the demand for advanced ELIZA systems, including automated immunoassay platforms, fueling segment expansion.
Automated ELISA analyzers have various advantages over semi-automated ELISA analyzers. Thus, this makes them a preferred choice in testing laboratories. For instance, automation provides the possibility of a walk-away workflow that saves time. Also, other benefits of automated ELISA analyzers include increased accuracy in results, cost efficiency, and fast turnaround times.
According to May 2023 data from Berthold Technologies GmbH & Co.KG, automated ELIZA analyzers increase detection efficiency and help boost overall operation. Moreover, as per the same source, automation in ELISA systems can turn an ELISA's manual and tedious process into an easy, fast, and technician-free activity. Thus, several benefits associated with them are anticipated to bolster their adoption during the forecast period.
In addition, automation provides an increase in flexibility. For instance, with the help of software and robotic components, automated analyzers can turn into a flexible workstation that can easily adapt to the required application. Hence, these benefits lead to a surge in their demand, thereby driving the growth of the segment.
In addition, key companies operating in the market are adopting strategies to provide advanced automated ELISA analyzers. This, in turn, leads to a surge in demand for automated analyzers, thereby driving the growth of the segment. For instance, in May 2022, Molecular Devices LLC launched fully automated work cells for ELISA workflows that automate and streamline the ELISA detection, allowing a rapid and robust analysis of large-volume samples.
Thus, the above-mentioned factors, like the increasing burden of infectious diseases, rising preference for automated ELIZA analyzers owing to several associated benefits, and several strategic initiatives undertaken by market players, are projected to augment segment expansion during the forecast period.
North America is Expected to Hold a Significant Share in the Market During the Forecast Period
North America is expected to dominate the market. This is due to the surge in the prevalence of infectious diseases such as HIV, Lyme disease, hepatitis C, and other diseases that require ELISA testing. For instance, FAIR Health released a study in August 2022. The study claimed a substantial rise in Lyme disease diagnoses throughout the last decade in the United States rural and urban areas. Also, the results of the study indicated that private insurance claims associated with Lyme disease diagnoses increased by 357% in rural areas and 65% in urban areas.
Similarly, the alarming increase in infectious diseases like tuberculosis, malaria, respiratory infections, and other diseases has bolstered the demand for advanced immunoassay solutions. For instance, according to the CDC’s updated data for November 2023, tuberculosis is a disease with a significant burden in the United States that affected around 8,331 people in the country in 2022. In addition, an estimated 13 million people are living with latent TB infection in the United States. Thus, the surge in prevalence of infectious diseases in the region leads to a surge in demand for ELISA analyzers thereby driving the growth of the market.
Moreover, the rising adoption of ELISA-based systems in point-of-care settings is further projected to propel market growth forward. For instance, according to the Journal of HHS Public Access published in February 2022, ELISA systems have emerged as a potential POC diagnostic tool owing to the development of automated plate reader systems and easy operations. Moreover, technological advancements in immunoassay platforms and cost efficiency have made it a convenient tool for POC applications. Thus, the higher adoption of ELIZA systems in POC settings is projected to spur regional market growth.
Also, factors such as the presence of key players in the region lead to the easy availability of advanced automated ELISA analyzers, contributing to the market's growth. Some of the key players operating in the region include PerkinElmer Inc. (EUROIMMUN Medizinische Labordiagnostika AG), Eurofins Scientific (Eurofins Abraxis), Gold Standard Diagnostics Inc. (NovaTec Immundiagnostica GmbH), and Awareness Technology Inc. Therefore, the increasing burden of infectious disease, technological advancements in ELIZA platforms, and increasing adoption of ELIZA systems at POC are projected to support the market growth over the coming years.
ELISA Analyzer Industry Overview
The ELISA analyzer market is consolidated due to the presence of a limited number of companies operating around the globe. The competitive landscape includes an analysis of a few international and local companies that operate in the market, such as Dynex Technologies Inc., Berthold Technologies GmbH & Co. KG, Grifols SA, Eurofins Scientific (Eurofins Abraxis), PerkinElmer Inc. (EUROIMMUN Medizinische Labordiagnostika AG), Hamilton Company, BIOLINE Medical System, Gold Standard Diagnostics Inc. (NovaTec Immundiagnostica GmbH), Awareness Technology Inc., and Everex S.r.l.
ELISA Analyzer Market Leaders
-
Dynex Technologies Inc
-
Berthold Technologies GmbH & Co.KG
-
Grifols, S.A.
-
Eurofins Scientific (Eurofins Abraxis)
-
PerkinElmer Inc. (EUROIMMUN Medizinische Labordiagnostika AG)
- *Disclaimer: Major Players sorted in no particular order
ELISA Analyzer Market News
- April 2023: Tecan and DYNEX Technologies partnered to accelerate the supply of advanced ELISA systems in the United States. This partnership allowed both companies to strengthen their customer reach across the United States.
- November 2023: Awareness Technology Inc. exhibited its ELISA strip reader and automated ELISA/CLIA analyzer at MEDICA 2023. In this exhibition, the company showcased the ability of the ELISA/Chemiluminescent analyzer to offer two plate solutions for a range of applications.
ELISA Analyzer Industry Segmentation
As per the scope of the report, ELISA analyzers are analytical instruments that perform a basic function needed to process an ELISA. These functions include reagent dispensing, microplate washing, incubation, and absorbance measurement.
The ELISA analyzers market is segmented by type of operation, modality, application, end user, and geography. Based on the type of operation, the market is segmented into automated ELISA analyzers and semi-automated analyzers. Based on the modality, the market is segmented into bench-top and stand-alone. Based on application, the market is segmented into vaccine development, immunology, drug monitoring, the pharmaceutical industry, and others. Based on end users, the market is segmented as diagnostic laboratories, pharmaceutical and biotechnology companies, contract research organizations, and other end users. The report also covers the market sizes and forecasts for the ELIZA analyzer market in major countries across different regions. For each segment, the market size is provided in terms of value (USD).
| By Type of Operation | Automated ELISA Analyzer | ||
| Semi-Automated Analyzer | |||
| By Modality | Bench-top | ||
| Stand-alone | |||
| By Application | Vaccines Development | ||
| Immunology | |||
| Drug Monitoring and Pharmaceutical Industry | |||
| Other Applications | |||
| By End User | Diagnostic Laboratories | ||
| Pharmaceutical and Biotechnology Companies | |||
| Contract Research Organizations | |||
| Other End Users | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Rest of the World | |||
| Automated ELISA Analyzer |
| Semi-Automated Analyzer |
| Bench-top |
| Stand-alone |
| Vaccines Development |
| Immunology |
| Drug Monitoring and Pharmaceutical Industry |
| Other Applications |
| Diagnostic Laboratories |
| Pharmaceutical and Biotechnology Companies |
| Contract Research Organizations |
| Other End Users |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| Australia | |
| South Korea | |
| Rest of Asia-Pacific | |
| Rest of the World |
ELISA Analyzer Market Research Faqs
How big is the ELISA Analyzer Market?
The ELISA Analyzer Market size is expected to reach USD 1.06 billion in 2025 and grow at a CAGR of 3.5% to reach USD 1.25 billion by 2030.
What is the current ELISA Analyzer Market size?
In 2025, the ELISA Analyzer Market size is expected to reach USD 1.06 billion.
Who are the key players in ELISA Analyzer Market?
Dynex Technologies Inc, Berthold Technologies GmbH & Co.KG, Grifols, S.A., Eurofins Scientific (Eurofins Abraxis) and PerkinElmer Inc. (EUROIMMUN Medizinische Labordiagnostika AG) are the major companies operating in the ELISA Analyzer Market.
Which is the fastest growing region in ELISA Analyzer Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in ELISA Analyzer Market?
In 2025, the North America accounts for the largest market share in ELISA Analyzer Market.
What years does this ELISA Analyzer Market cover, and what was the market size in 2024?
In 2024, the ELISA Analyzer Market size was estimated at USD 1.02 billion. The report covers the ELISA Analyzer Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the ELISA Analyzer Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
ELISA Analyzer Industry Report
Statistics for the 2025 ELISA Analyzer market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. ELISA Analyzer analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
